SCHEMBL23573000

SCHEMBL23573000

Fc1cc(OCc2ccccc2)cc(F)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.56
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
CYP3A4 P08684 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A2 P23975 1/20 0.50
CYP2C19 P33261 1/20 0.50
PTGS2 P35354 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HIF1A Q16665 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
MAOB P27338 5/20 0.49
RAB9A P51151 2/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
MAOA P21397 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21244393 0.88 ALOX5 (0.49) ALOX5MEN1KMT2ACYP3A4LMNA
SCHEMBL21288704 0.85 ALOX5 (0.46) ALOX5MEN1KMT2ACYP3A4LMNA
SCHEMBL21244441 0.82 CA9 (0.52) ALOX5MEN1KMT2AMAOBRAB9A
SCHEMBL29862640 0.82 CA9 (0.52) ALOX5MEN1KMT2AMAOBRAB9A
SCHEMBL4674930 0.81 MEN1 (0.70) ALOX5MEN1KMT2ALMNACYP1A2
SCHEMBL5042093 0.80 ALOX5 (0.55) ALOX5MEN1KMT2ALMNACYP1A2
SCHEMBL31160636 0.80 MEN1 (0.59) ALOX5MEN1KMT2ALMNACYP1A2
SCHEMBL2521216 0.80 ALOX5 (0.60) ALOX5MEN1KMT2ACYP3A4LMNA
SCHEMBL22305218 0.78 MAOB (0.64) ALOX5MEN1KMT2ALMNACYP1A2
SCHEMBL15984861 0.77 ALOX5 (0.56) ALOX5MEN1KMT2ACYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 US disclosed
EP-4308575-A1 MACROCYCLES AS CFTR MODULATORS Idorsia Pharmaceuticals Ltd (CH) 2024-01-24 EP disclosed
US-20230391703-A1 SELECTIVE HYDRODEOXYGENATION OF AROMATIC COMPOUNDS UNIVERSITY OF SOUTH CAROLINA 2023-12-07 US disclosed
CN-116981672-A Macrocyclic compounds as CFTR modulators 爱杜西亚药品有限公司 2023-10-31 CN disclosed
US-11773040-B2 Selective hydrodeoxygenation of aromatic compounds BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2023-10-03 US disclosed
US-11773040-B2 Selective hydrodeoxygenation of aromatic compounds BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2023-10-03 US disclosed
US-11773040-B2 Selective hydrodeoxygenation of aromatic compounds BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2023-10-03 US disclosed
WO-2022194399-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2022-09-22 WO disclosed
US-20210198171-A1 SELECTIVE HYDRODEOXYGENATION OF AROMATIC COMPOUNDS UNIVERSITY OF SOUTH CAROLINA 2021-07-01 US disclosed
US-20210198171-A1 SELECTIVE HYDRODEOXYGENATION OF AROMATIC COMPOUNDS UNIVERSITY OF SOUTH CAROLINA 2021-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198171-A1 SELECTIVE HYDRODEOXYGENATION OF AROMATIC COMPOUNDS H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, PAH ALOX5 413/4885MEN1 4669/4885KMT2A 2374/4885
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS CFTR, PKD1, ARRB1 ALOX5 4063/4885MEN1 1575/4885KMT2A 4313/4885
US-11773040-B2 Selective hydrodeoxygenation of aromatic compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, PAH ALOX5 413/4885MEN1 4669/4885KMT2A 2374/4885
US-20230391703-A1 SELECTIVE HYDRODEOXYGENATION OF AROMATIC COMPOUNDS H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, PAH ALOX5 413/4885MEN1 4669/4885KMT2A 2374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.